Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Feasibility of Reversible Conduction Block Generated Using Peripheral Nerve Stimulator in Treatment of Focal Spasticity and the Stimulation Parameters for the Same.

NCT06868342 is registered in ClinicalTrials.gov with Walton Centre NHS Foundation Trust as lead sponsor.

NCT NCT06868342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06868342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Feasibility of Reversible Conduction Block Generated Using Peripheral Nerve Stimulator in Treatment of Focal Spasticity and the Stimulation Parameters for the Same.
Lead sponsor
Walton Centre NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2024
Completion date
December 9, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spasticity, spasticity in participants with multiple sclerosis, spasticity post stroke, spasticity related to any cause except cerebral palsy